• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种相关蛋白中保守组氨酸结构状态的明显差异:趋化因子CXCL1和CXCL8游离形式及大分子复合物的核磁共振研究

Distinct Differences in Structural States of Conserved Histidines in Two Related Proteins: NMR Studies of the Chemokines CXCL1 and CXCL8 in the Free Form and Macromolecular Complexes.

作者信息

Sepuru Krishna Mohan, Rajarathnam Krishna

出版信息

Biochemistry. 2018 Oct 16;57(41):5969-5977. doi: 10.1021/acs.biochem.8b00756. Epub 2018 Oct 2.

DOI:10.1021/acs.biochem.8b00756
PMID:30230320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6794194/
Abstract

Hydrogen-bonding and ionic interactions play fundamental roles in macromolecular recognition and function. In contrast to lysines and arginines, how histidines mediate these interactions is less well-understood due to the unique properties of its side chain imidazole that include an aromatic ring with two titratable nitrogens, a p K that can vary significantly, and the ability to exist in three distinct forms: protonated imidazolium and two tautomeric neutral (N and N) states. Here, we characterized the structural features of histidines in the chemokines CXCL8 and CXCL1 in the free, GAG heparin-bound, and CXCR2 receptor N-terminal domain-bound states using solution NMR spectroscopy. CXCL8 and CXCL1 share two conserved histidines, one in the N-loop and the other in the 30s loop. In CXCL8, both histidines exist in the N tautomeric state in the free, GAG-bound, and receptor-bound forms. On the other hand, in unliganded CXCL1, each of the two histidines exists in two states, as the neutral N tautomer and charged imidazolium. Further, both histidines exclusively exist as the imidazolium in the GAG-bound and as the N tautomer in the receptor-bound forms. The N-loop histidine alone in both chemokines is involved in direct GAG and receptor interactions, indicating the role of the 30s loop varies between the chemokines. Our observation that the structural features of conserved histidines and their functional role in two related proteins can be quite different is novel. We further propose that directly probing the imidazole structural features is essential to fully appreciate the molecular basis of histidine function.

摘要

氢键和离子相互作用在大分子识别和功能中起着基础性作用。与赖氨酸和精氨酸不同,由于组氨酸侧链咪唑具有独特性质,包括带有两个可滴定氮的芳香环、可显著变化的pK以及能够以三种不同形式存在(质子化咪唑鎓和两种互变异构中性(N1和N3)状态),组氨酸如何介导这些相互作用尚不太清楚。在此,我们使用溶液核磁共振波谱法表征了趋化因子CXCL8和CXCL1中组氨酸在游离、与GAG肝素结合以及与CXCR2受体N端结构域结合状态下的结构特征。CXCL8和CXCL1共有两个保守组氨酸,一个在N环,另一个在30s环。在CXCL8中,两个组氨酸在游离、与GAG结合以及与受体结合形式下均以N1互变异构状态存在。另一方面,在未结合配体的CXCL1中,两个组氨酸各自以两种状态存在,即中性N1互变异构体和带电荷的咪唑鎓。此外,两个组氨酸在与GAG结合时仅以咪唑鎓形式存在,在与受体结合时以N1互变异构体形式存在。两种趋化因子中单独的N环组氨酸参与直接的GAG和受体相互作用,表明30s环在趋化因子之间的作用有所不同。我们观察到两个相关蛋白中保守组氨酸的结构特征及其功能作用可能有很大差异,这是新颖的。我们进一步提出,直接探究咪唑的结构特征对于充分理解组氨酸功能的分子基础至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6794194/3b4976a72ffa/nihms-1053178-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6794194/91308c5a39fd/nihms-1053178-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6794194/a05d3f1c4972/nihms-1053178-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6794194/2de34ec852b0/nihms-1053178-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6794194/3f2bdc833d7c/nihms-1053178-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6794194/3748f023d2a7/nihms-1053178-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6794194/f859fb5d63e1/nihms-1053178-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6794194/4b0b1f19e622/nihms-1053178-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6794194/3b4976a72ffa/nihms-1053178-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6794194/91308c5a39fd/nihms-1053178-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6794194/a05d3f1c4972/nihms-1053178-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6794194/2de34ec852b0/nihms-1053178-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6794194/3f2bdc833d7c/nihms-1053178-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6794194/3748f023d2a7/nihms-1053178-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6794194/f859fb5d63e1/nihms-1053178-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6794194/4b0b1f19e622/nihms-1053178-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6794194/3b4976a72ffa/nihms-1053178-f0008.jpg

相似文献

1
Distinct Differences in Structural States of Conserved Histidines in Two Related Proteins: NMR Studies of the Chemokines CXCL1 and CXCL8 in the Free Form and Macromolecular Complexes.两种相关蛋白中保守组氨酸结构状态的明显差异:趋化因子CXCL1和CXCL8游离形式及大分子复合物的核磁共振研究
Biochemistry. 2018 Oct 16;57(41):5969-5977. doi: 10.1021/acs.biochem.8b00756. Epub 2018 Oct 2.
2
CXCL1/MGSA Is a Novel Glycosaminoglycan (GAG)-binding Chemokine: STRUCTURAL EVIDENCE FOR TWO DISTINCT NON-OVERLAPPING BINDING DOMAINS.CXCL1/MGSA是一种新型的糖胺聚糖(GAG)结合趋化因子:两个不同且不重叠结合域的结构证据。
J Biol Chem. 2016 Feb 19;291(8):4247-55. doi: 10.1074/jbc.M115.697888. Epub 2015 Dec 31.
3
Chemokine CXCL7 Heterodimers: Structural Insights, CXCR2 Receptor Function, and Glycosaminoglycan Interactions.趋化因子CXCL7异二聚体:结构解析、CXCR2受体功能及糖胺聚糖相互作用
Int J Mol Sci. 2017 Apr 1;18(4):748. doi: 10.3390/ijms18040748.
4
Molecular Basis of Chemokine CXCL5-Glycosaminoglycan Interactions.趋化因子CXCL5与糖胺聚糖相互作用的分子基础。
J Biol Chem. 2016 Sep 23;291(39):20539-50. doi: 10.1074/jbc.M116.745265. Epub 2016 Jul 28.
5
Heparin-bound chemokine CXCL8 monomer and dimer are impaired for CXCR1 and CXCR2 activation: implications for gradients and neutrophil trafficking.肝素结合趋化因子 CXCL8 单体和二聚体对 CXCR1 和 CXCR2 的激活作用受损:对梯度和中性粒细胞迁移的影响。
Open Biol. 2017 Nov;7(11). doi: 10.1098/rsob.170168.
6
Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors.探讨趋化因子 CXCL8 中 CXC 基序在高亲和力结合和激活 CXCR1 和 CXCR2 受体中的作用。
J Biol Chem. 2010 Sep 17;285(38):29262-9. doi: 10.1074/jbc.M110.146555. Epub 2010 Jul 14.
7
Structural Basis of Native CXCL7 Monomer Binding to CXCR2 Receptor N-Domain and Glycosaminoglycan Heparin.天然CXCL7单体与CXCR2受体N结构域及糖胺聚糖肝素结合的结构基础
Int J Mol Sci. 2017 Feb 26;18(3):508. doi: 10.3390/ijms18030508.
8
Molecular basis of glycosaminoglycan heparin binding to the chemokine CXCL1 dimer.糖胺聚糖肝素与趋化因子 CXCL1 二聚体相互作用的分子基础。
J Biol Chem. 2013 Aug 30;288(35):25143-25153. doi: 10.1074/jbc.M113.492579. Epub 2013 Jul 17.
9
Chemokine CXCL1 dimer is a potent agonist for the CXCR2 receptor.趋化因子 CXCL1 二聚体是 CXCR2 受体的有效激动剂。
J Biol Chem. 2013 Apr 26;288(17):12244-52. doi: 10.1074/jbc.M112.443762. Epub 2013 Mar 11.
10
Structural basis, stoichiometry, and thermodynamics of binding of the chemokines KC and MIP2 to the glycosaminoglycan heparin.化学趋化因子 KC 和 MIP2 与糖胺聚糖肝素结合的结构基础、化学计量和热力学。
J Biol Chem. 2018 Nov 16;293(46):17817-17828. doi: 10.1074/jbc.RA118.004866. Epub 2018 Sep 26.

引用本文的文献

1
NMR Methods for Characterization of Glycosaminoglycan-Chemokine Interactions.NMR 方法用于鉴定糖胺聚糖-趋化因子相互作用。
Methods Mol Biol. 2023;2597:143-157. doi: 10.1007/978-1-0716-2835-5_12.
2
Long-Range Coupled Motions Underlie Ligand Recognition by a Chemokine Receptor.趋化因子受体识别配体的基础是长程耦合运动。
iScience. 2020 Nov 26;23(12):101858. doi: 10.1016/j.isci.2020.101858. eCollection 2020 Dec 18.
3
Structural Insights Into How Proteoglycans Determine Chemokine-CXCR1/CXCR2 Interactions: Progress and Challenges.蛋白聚糖如何决定趋化因子-CXCR1/CXCR2 相互作用的结构见解:进展与挑战。
Front Immunol. 2020 Apr 24;11:660. doi: 10.3389/fimmu.2020.00660. eCollection 2020.
4
Structural basis of chemokine interactions with heparan sulfate, chondroitin sulfate, and dermatan sulfate.化学趋化因子与肝素硫酸、软骨素硫酸和硫酸皮肤素相互作用的结构基础。
J Biol Chem. 2019 Oct 25;294(43):15650-15661. doi: 10.1074/jbc.RA119.009879. Epub 2019 Aug 27.

本文引用的文献

1
Glycosaminoglycan Interactions Fine-Tune Chemokine-Mediated Neutrophil Trafficking: Structural Insights and Molecular Mechanisms.糖胺聚糖精细调控趋化因子介导的中性粒细胞迁移:结构见解和分子机制。
J Histochem Cytochem. 2018 Apr;66(4):229-239. doi: 10.1369/0022155417739864. Epub 2018 Jan 1.
2
Regulation of Chemokine-Receptor Interactions and Functions.趋化因子-受体相互作用和功能的调节。
Int J Mol Sci. 2017 Nov 14;18(11):2415. doi: 10.3390/ijms18112415.
3
Heparin-bound chemokine CXCL8 monomer and dimer are impaired for CXCR1 and CXCR2 activation: implications for gradients and neutrophil trafficking.肝素结合趋化因子 CXCL8 单体和二聚体对 CXCR1 和 CXCR2 的激活作用受损:对梯度和中性粒细胞迁移的影响。
Open Biol. 2017 Nov;7(11). doi: 10.1098/rsob.170168.
4
Interplay of extracellular matrix and leukocytes in lung inflammation.细胞外基质与白细胞在肺部炎症中的相互作用。
Cell Immunol. 2017 Feb;312:1-14. doi: 10.1016/j.cellimm.2016.12.003. Epub 2016 Dec 23.
5
CXCL1/MGSA Is a Novel Glycosaminoglycan (GAG)-binding Chemokine: STRUCTURAL EVIDENCE FOR TWO DISTINCT NON-OVERLAPPING BINDING DOMAINS.CXCL1/MGSA是一种新型的糖胺聚糖(GAG)结合趋化因子:两个不同且不重叠结合域的结构证据。
J Biol Chem. 2016 Feb 19;291(8):4247-55. doi: 10.1074/jbc.M115.697888. Epub 2015 Dec 31.
6
The sweet spot: how GAGs help chemokines guide migrating cells.最佳点:糖胺聚糖如何帮助趋化因子引导迁移细胞。
J Leukoc Biol. 2016 Jun;99(6):935-53. doi: 10.1189/jlb.3MR0915-440R. Epub 2015 Dec 23.
7
Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions.趋化因子CXCL8/IL-8单体和二聚体与糖胺聚糖结合的溶液核磁共振表征:结构可塑性介导不同的结合相互作用。
Biochem J. 2015 Nov 15;472(1):121-33. doi: 10.1042/BJ20150059. Epub 2015 Sep 14.
8
Solution NMR characterization of WT CXCL8 monomer and dimer binding to CXCR1 N-terminal domain.野生型CXCL8单体和二聚体与CXCR1 N端结构域结合的溶液核磁共振表征。
Protein Sci. 2015 Jan;24(1):81-92. doi: 10.1002/pro.2590. Epub 2014 Nov 28.
9
pH-dependent random coil (1)H, (13)C, and (15)N chemical shifts of the ionizable amino acids: a guide for protein pK a measurements.可电离氨基酸的pH依赖性无规卷曲(1)H、(13)C和(15)N化学位移:蛋白质pKa测量指南
J Biomol NMR. 2014 Nov;60(2-3):109-29. doi: 10.1007/s10858-014-9862-y. Epub 2014 Sep 20.
10
Chemokine CXCL1 dimer is a potent agonist for the CXCR2 receptor.趋化因子 CXCL1 二聚体是 CXCR2 受体的有效激动剂。
J Biol Chem. 2013 Apr 26;288(17):12244-52. doi: 10.1074/jbc.M112.443762. Epub 2013 Mar 11.